M1116 Levofloxacin-Based Sequential Therapy vs Clarithromycin-Based Sequential Therapy for Eradication of H. pylori Infection

s / Digestive and Liver Disease 42S (2010) S61–S192 S113 (ITT) analysis, respectively; 3) Eradication rate in the CLA-ST group was 62/73 (84.9%) and 62/75(82.6%) in the PP and ITT analysis, respectively; 4) The difference in the eradication rate between LEV-ST and CLA-ST was statistically significant (p<0.001) by χ2 test in both PP and ITT analysis; 5) No significant differences in the incidence of adverse events was observed. Conclusions: This study indicates that in an area of high prevalence of CLA-resistant H. pylori strains, a modified, LEV-based ST is well tolerated and significantly superior to standard, CLA-based ST for eradication of H. pylori infection. # B. Gastric diseases 3. H. pylori basic/diagnosis/therapy